Skin Irritation Study of GSK2894512 Cream

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

October 27, 2015

Primary Completion Date

December 2, 2015

Study Completion Date

December 2, 2015

Conditions
Dermatitis, Atopic
Interventions
DRUG

GSK2894512 Cream

GSK2894512 cream supplied will be white to off-white cream packaged in 28-gram laminate tubes of 2 concentrations: 0.5% and 1%, to be applied topically.

DRUG

Vehicle Cream

Vehicle Cream (placebo cream without active ingredient) supplied will be white to off-white cream packaged in 28-gram laminate tubes, to be applied topically.

DRUG

Empty Patch

Empty patches without any ingredients will be used as negative control.

Trial Locations (1)

812-0025

GSK Investigational Site, Fukuoka

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY